Cable Hill Partners, LLC Acadia Pharmaceuticals Inc Transaction History

Cable Hill Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$14.32 - $22.92 $14,320 - $22,920	-1,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$13.03 - $21.81 $6,515 - $10,905	500 Added 100.0%	1,000 $21,000
Q2 2018 Aug 03, 2018	BUY	$15.07 - $22.34 $7,535 - $11,170	500 New	500 $8,000
Q1 2018 Apr 20, 2018	SELL	$22.47 - $32.33 $8,988 - $12,932	-400 Closed	0 $0
Q4 2017 Feb 22, 2018	BUY	$26.84 - $39.14 $10,736 - $15,656	400	400 $12,000

299

158M

1.88M

688K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.